This site is new - feedback and suggestions welcome via GitHub issues.

#cancer — Monday, August 03, 2026 (9 items)

0 💬 0 The cGAS/STING pathway in cancer: translating innate DNA sensing into therapeutic potential. (jci.org) robot Wang Y Deng L Journal of Clinical Investigation 2026-08-03 #immunity #cancer #immunotherapy #innate #inflammation
0 💬 0 Cell surface ADGRG1 and CD86 expression identifies antitumor CD4(+) T cells in human cancer. (pnas.org) robot Hitscherich KJ Lowery FJ PNAS 2026-08-03 #cancer #immunotherapy #t cell #proteomics #transcriptomics
0 💬 0 FGFR3-driven gene regulatory network analysis reveals a protumoral role for p63 in luminal bladder tumors. (jci.org) robot Moreno-Vega A Bernard-Pierrot I Journal of Clinical Investigation 2026-08-03 #transcriptomics #cancer #signaling #oncogene #regulation
0 💬 0 The BAX/BAK apoptotic checkpoint polices entry to therapy-induced senescence. (linkinghub.elsevier.com) robot Gallagher Aldave A Martin SJ Cell Chemical Biology 2026-08-03 #apoptosis #senescence #mitochondrial #chemotherapy #cancer
0 💬 0 Protein neddylation as a therapeutic target: challenges and opportunities. (jci.org) robot Zhang S Sun Y Journal of Clinical Investigation 2026-08-03 #neddylation #ptm #cancer #therapeutics #ubiquitin
0 💬 0 Addition of High-Dose Vitamin D3 to Standard Treatment in Patients With Metastatic Colorectal Cancer: The SOLARIS Randomized Clinical Trial (Alliance A021703). (jamanetwork.com) robot Ng K Meyerhardt JA JAMA 2026-08-03 #cancer #chemotherapy #colorectal #immunonutrition
0 💬 0 Evolution of botulinum neurotoxin serotype X proteases to induce inflammatory cell death in cancer cells. (nature.com) robot McCreary J Liu DR Nature Biotechnology 2026-08-03 #cancer #cell death #proteases #protein design #immunotherapy
0 💬 0 CIP2A-TOPBP1 complex and PP2A dynamically regulate Poltheta recruitment and phosphorylation at mitotic DNA double-strand breaks. (pnas.org) robot Zhao X Zhao G PNAS 2026-08-03 #dna repair #mitosis #phosphorylation #cancer
0 💬 0 Discovery of a covalent FGFR2-selective inhibitor overcoming clinically-acquired resistance mutations. (nature.com) robot Huang X Chen L Nature Communications 2026-08-03 #kinase inhibitor #drug resistance #cancer #structure_based_design #covalent-inhibition